PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
57.79%
Revenue growth above 1.5x OBE's 2.54%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
142.67%
Positive gross profit growth while OBE is negative. John Neff would see a clear operational edge over the competitor.
1020.37%
EBIT growth above 1.5x OBE's 114.29%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
1020.37%
Operating income growth above 1.5x OBE's 88.98%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
253.38%
Net income growth above 1.5x OBE's 111.64%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
234.15%
EPS growth above 1.5x OBE's 110.64%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
234.15%
Diluted EPS growth above 1.5x OBE's 110.84%. David Dodd would see if there's a robust moat protecting these shareholder gains.
13.36%
Share count expansion well above OBE's 1.84%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
13.36%
Diluted share count expanding well above OBE's 0.26%. Michael Burry would fear significant dilution to existing owners' stakes.
-5.49%
Dividend reduction while OBE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-46.73%
Negative OCF growth while OBE is at 186.36%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-90.26%
Negative FCF growth while OBE is at 112.77%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-76.60%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-45.44%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-47.79%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-94.94%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-87.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-91.44%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-20.96%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
2617.93%
Positive 5Y CAGR while OBE is negative. John Neff might view this as a strong mid-term relative advantage.
182.96%
3Y net income/share CAGR 1.25-1.5x OBE's 127.43%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
-64.84%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
-41.72%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-5.06%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
-91.06%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-92.28%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-77.60%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
77.76%
Our AR growth while OBE is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
0.29%
Positive asset growth while OBE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-6.04%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-1.10%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
2.27%
We expand SG&A while OBE cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.